Literature DB >> 3790150

Changes in methionine metabolism induced by D-galactosamine in isolated rat hepatocytes.

M Ozturk, F Lemonnier, D Cresteil, A Lemonnier.   

Abstract

We studied several steps of methionine metabolism in isolated rat hepatocytes both with and without the presence of a hepatotoxic agent (D-galactosamine). By use of selective labelling either on methyl or on carboxyl groups, we showed that intracellular methionine is used preferentially for the methylation of phospholipids (42%) and nucleic acids (31%) via S-adenosylmethionine. In the presence of D-galactosamine, the incorporation of L-(14CH3) methionine into macromolecules is significantly inhibited (greater than 50%). This inhibition is associated with a decrease of S-adenosylmethionine and an increase of methionine in the injured cells. These results suggest that hepatotoxicity of galactosamine may be due in part to an inhibition of the methylation of nucleic acids and phospholipids. Consequently, we hypothesize that hypermethioninemia associated with human liver disease could be due, at least partly, to a defect in synthesis and/or utilization of S-adenosylmethionine by hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3790150     DOI: 10.1016/0006-2952(86)90699-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  Acute liver injury induces nucleocytoplasmic redistribution of hepatic methionine metabolism enzymes.

Authors:  Miguel Delgado; Francisco Garrido; Juliana Pérez-Miguelsanz; María Pacheco; Teresa Partearroyo; Dolores Pérez-Sala; María Angeles Pajares
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

2.  Susceptibility of Asialoglycoprotein Receptor-Deficient Mice to Lps/Galactosamine Liver Injury and Protection by Betaine Administration.

Authors:  Karuna Rasineni; Serene M L Lee; Benita L McVicker; Natalia A Osna; Carol A Casey; Kusum K Kharbanda
Journal:  Biology (Basel)       Date:  2020-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.